CFDE Data Portal | Search HNRNPA3P2

	Label	Description
	HNRNPA3P2 associations Collection (Entity type)	Associations for HNRNPA3P2_associations
	HNRNPA3P2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	HNRNPA3P2 Gene (Entity type)	ENSG00000227688 - heterogeneous nuclear ribonucleoprotein A3 pseudogene 2
	GSE174745 dopamine neuron 1 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE160182 GSE160183 IKAROS GFI1 knockout 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE212074 PUS1 knockdown MDA-MB-231 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158438 lenalidomide IRCC-Neuromed-FL 4 v 12 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

HNRNPA3P2 associations

Associations for HNRNPA3P2_associations

HNRNPA3P2 associations.tsv

A file from IDG as part of the Harmonizome project

HNRNPA3P2

ENSG00000227688 - heterogeneous nuclear ribonucleoprotein A3 pseudogene 2

GSE174745 dopamine neuron 1 v 8 human up

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 3 human up

A Gene Set from LINCS

GSE160182 GSE160183 IKAROS GFI1 knockout 2 v 0 human dn

A Gene Set from LINCS

GSE212074 PUS1 knockdown MDA-MB-231 0 v 1 human up

A Gene Set from LINCS

GSE158438 lenalidomide IRCC-Neuromed-FL 4 v 12 human dn

A Gene Set from LINCS

GSE201309 matrine 5 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.